title: Clinical genetics of Kallmann syndrome.
abstract: The Kallmann syndrome (KS) combines hypogonadotropic hypogonadism (HH) with anosmia. This is a clinically and genetically heterogeneous disease. KAL1, encoding the extracellular glycoprotein anosmin-1, is responsible for the X chromosome-linked recessive form of the disease (KAL1). Mutations in FGFR1 or FGF8, encoding fibroblast growth factor receptor-1 and fibroblast growth factor-8, respectively, underlie an autosomal dominant form with incomplete penetrance (KAL2). Mutations in PROKR2 and PROK2, encoding prokineticin receptor-2 and prokineticin-2, have been found in heterozygous, homozygous, and compound heterozygous states. These two genes are likely to be involved both in autosomal recessive monogenic (KAL3) and digenic/oligogenic KS transmission modes. Mutations in any of the above-mentioned KS genes have been found in less than 30% of the KS patients, which indicates that other genes involved in the disease remain to be discovered. Notably, KS may also be part of pleiotropic developmental diseases including CHARGE syndrome; this disease results in most cases from neomutations in CHD7 that encodes a chromodomain helicase DNA-binding protein.
authors.affiliation: Inserm U1016, département de génétique et développement, institut Cochin, 27, rue du Faubourg-Saint-Jacques, 75679 Paris cedex 14, France. catherine.dode@inserm.fr
authors.forename: C
authors.initials: C
authors.lastname: Dodé
authors.forename: J-P
authors.initials: JP
authors.lastname: Hardelin
mesh_terms: D000015:Abnormalities, Multiple / Q000235:genetics; D015914:Estrogen Replacement Therapy / Q000379:methods; D016326:Extracellular Matrix Proteins / Q000235:genetics*; D005260:Female; D018095:Germ-Line Mutation; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D017436:Kallmann Syndrome / Q000235:genetics* / Q000503:physiopathology; D009154:Mutation; D020125:Mutation, Missense; D009419:Nerve Tissue Proteins / Q000235:genetics*; D051496:Receptor, Fibroblast Growth Factor, Type 1 / Q000235:genetics*
chemical_list: C076266:ANOS1 protein, human; D016326:Extracellular Matrix Proteins; D009419:Nerve Tissue Proteins; C496348:FGFR1 protein, human; D051496:Receptor, Fibroblast Growth Factor, Type 1